UMIN ID: UMIN000055438
Registered date:06/09/2024
A systematic review of mitochondrial transplantation therapy on cancer care
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Cancer, Cachexia, Sarcopenia, Muscle injury |
| Date of first enrollment | 2024/09/06 |
| Target sample size | |
| Countries of recruitment | North America |
| Study type | Others,meta-analysis etc |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Biological or physiological measures of the cancer, cachexia, or sarcopenia/muscle injury |
|---|---|
| Secondary Outcome | Safety |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. Studies that used a mesenchymal stem cell-mediated transfer of mitochondria as a transfer method |
Related Information
| Primary Sponsor | Feinstein Institutes for Medical Research |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Feinstein Institutes for Medical Research |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Kei Hayashida |
| Address | 350 Community Dr, Manhasset, NY Japan 11030 |
| Telephone | 1-516-562-1305 |
| keilinda0714@gmail.com | |
| Affiliation | Feinstein Institutes for Medical Research Laboratory for Critical Care Physiology |
| scientific contact | |
| Name | Kei Hayashida |
| Address | 350 Community Dr, Manhasset, NY Japan |
| Telephone | 1-516-562-1305 |
| khayashida@northwell.edu | |
| Affiliation | Feinstein Institutes for Medical Research Laboratory for Critical Care Physiology |